Exothera

Jumet, BE
AAV Adenoviral Lentiviral
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
78.1
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (4) ○ MHRA GMP

Quick Facts: Exothera

Signal Score
78.1/100 (as of 2026-04-29)
Quality Compliance
100.0/100 — No FDA inspection records found for this manufacturer
Headquarters
Jumet, BE
Modalities
AAV, Adenoviral, Lentiviral
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Exothera

Belgian viral vector CDMO.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates4 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Adenoviral, Lentiviral
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Jumet, Belgium
Modalities: AAV, Adenoviral, Lentiviral
Capacity assessment: 58.0/100
Sites: Jumet, Belgium
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Jumet, Belgium
Modalities: AAV, Adenoviral, Lentiviral
Capacity assessment: 58.0/100

Exothera EMA GMP Compliance 4 certificates

2023-11
2023-11
2023-11
2023-11
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
BE/GMP/2023/128 Exothera Belgium 2023-11-24 COMPLIANT
BE/GMP/2023/129 Exothera Belgium 2023-11-24 COMPLIANT
BE/GMP/2023/131 Exothera Belgium 2023-11-24 COMPLIANT
BE/GMP/2023/130 Exothera Belgium 2023-11-24 COMPLIANT
Source: EMA EudraGMDP · Retrieved Jul 04, 2026

Frequently Asked Questions About Exothera

Does Exothera hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for Exothera.
What is Exothera's CDMO Signal Score?
Exothera has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating Exothera for a manufacturing program?
Use the free AI matchmaker to compare Exothera against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Adenoviral CDMOs → Lentiviral CDMOs →

Similar CDMOs

Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 83.1
AAV, Lentiviral, Plasmid DNA, Adenoviral
Advent Bioservices
London, UK
Signal Score: 78.1
AAV, Lentiviral, Adenoviral
Vigene Biosciences
Rockville, MD
Signal Score: 72.5
AAV, Lentiviral, Adenoviral
CoJourney Inc.
Ambler, PA (US operations; primary manufacturing in Hangzhou, Zhejiang, China)
Signal Score: 60.0
Plasmid DNA, AAV, Adenoviral, Lentiviral, Retroviral, mRNA, sgRNA, Exosome
3P Biopharmaceuticals (now 3PBIOVIAN)
Pamplona-Noáin, Spain
Biologics (microbial & mammalian), AAV, Adenoviral, Lentiviral, Cell Therapy, Plasmid DNA, Recombinant Proteins, Biosimilars, Fill/Finish (recombinant proteins & viral vectors)